PANACEABIO.NSPANACEABIO.NSNSE
Loading
Operating cash flow minus capital expenditures
Percentile
P40
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-260.70M | +66.4% |
| 2025 | $-776.80M | +0.2% |
| 2024 | $-778.18M | +83.2% |
| 2023 | $-4.63B | -283.1% |
| 2022 | $-1.21B | -242.3% |
| 2021 | $850.01M | +327.4% |
| 2020 | $-373.81M | -137.4% |
| 2019 | $1.00B | -2.7% |
| 2018 | $1.03B | -3.7% |
| 2017 | $1.07B | - |